DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Contribución de congreso (ConferenceOutput)
BRCA2 mis-splicing: exons 17 and 18 regulation
Póster presentado a la European Human Genetics Conference, celebrada en Copenague (Dinamarca) del 27 al 30 de mayo de 2017., Mutation screening of BRCA2 identifies a large fraction of variants of uncertain clinical significance (VUS). Our goal was to investigate the impact of reported variants of BRCA2 exons 17 and 18 on splicing to assess their role in hereditary breast cancer and to identify critical regulatory elements that may constitute hotspots for spliceogenic variants. A splicing reporter minigene with BRCA2 exons 14 to-20 (MGBR2_ex14-20) was constructed in the pSAD vector. Fifty-two candidate variants were selected with splicing prediction programs, introduced in MGBR2_ex14-20 by site-directed mutagenesis and assayed in MCF-7 cells. Functional mapping by microdeletions revealed essential sequences for exon recognition on the 3' end of exon 17 and the 5' end of exon 18. Thirty out of the 52 selected variants induced anomalous splicing in minigene assays with >16 different aberrant transcripts, where exon skipping was the most common event. According to the biological indicators of pathogenicity, 18 variants could be classified as disease-causing, accounting for 28.6% of all pathogenic variants of exons 17-18 at the BRCA Share database. Aberrant splicing is especially prevalent in BRCA2 exons 17 and 18 due to the presence of active ESEs, which are recognized by splicing factor as SC35 and Tra2ß that play an important role in exon recognition. Splicing functional assays with minigenes are a valuable strategy for the interpretation of VUS of any disease-gene., Projects FIS PI13/01749 (ISCIII,Spanish Ministry of Economy and Competitivity), BIO/VA34/15 (Junta Castilla-León); EF-B is supported by a predoctoral fellowship (University of Valladolid/Banco Santander) and by a Short-Fellowship (EMBO)., Peer Reviewed
Project:
EC / H2020 634935
View at: http://hdl.handle.net/10261/158254